SINGAPORE — French pharmaceutical giant Sanofi on Wednesday opened a 800 million Singapore dollar ($595 million) "evolutive ...
Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be ...
About 200 people with the condition will be recruited for the trial, which will start in 2025. Read more at straitstimes.com.
Clinical trials for a revolutionary vaccine to treat acne will be conducted by the National Skin Centre in partnership with ...
Sanofi's $595m Singapore facility, Modulus, leverages advanced technology for rapid, flexible vaccine production, bolstering ...
The facility, known as Modulus, can switch between making different vaccines or treatments in a matter of days. It will contribute about 200 skilled jobs to Singapore, and will be fully ...
French pharma major Sanofi has added a new plant in Singapore to make vaccines and other medicines, as the company seeks to ...